Krka dd 2016 Annual Report with Sustainability Disclosures
The report highlights Krka Group's performance in 2016, during which the company achieved a record production of 13.5 billion tablets, capsules, and other pharmaceutical dosage forms. Despite price reductions and currency fluctuations that reduced net profit by 31% to ’108.5 million, sales increased by 1% in value to ’1,174.4 million and 11% in volume. Krka launched 19 new products and allocated ’132 million to investments, primarily to expand production and research-and-development capacities. On the sustainability front, the company reduced its drinking water consumption for pharmaceutical waters by 3% and increased its recyclable waste by 27%.
Company: Krka dd
Sector: Manufacturing
Country: Slovenia
Year: 2016
Type: Annual Report with Sustainability Disclosures
Pages: 264
Back to company
Krka dd
Annual Report
The report highlights Krka Group's performance in 2016, during which the company achieved a record production of 13.5 billion tablets, capsules, and other pharmaceutical dosage forms. Despite price reductions and currency fluctuations that reduced net profit by 31% to ’108.5 million, sales increased by 1% in value to ’1,174.4 million and 11% in volume. Krka launched 19 new products and allocated ’132 million to investments, primarily to expand production and research-and-development capacities. On the sustainability front, the company reduced its drinking water consumption for pharmaceutical waters by 3% and increased its recyclable waste by 27%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Employees